Application no. and date | 01994323.2 (espacenet) (Federated) (European Patent Register), 20011219 | Patent/reg. no. and date | DK/EP 1353916, 20060920 | Publication date | 20031022 | Priority no. and date | US 257887 P, 20001221, US 286949 P, 20010427 | EP pub. no. and date |
EP 1353916 20031022 | Effective date | | Applicant/owner | VERTEX PHARMACEUTICALS INCORPORATED, 130 Waverley Street
Cambridge, MA 01239-4212, US | Applicant ref. no. | P41685DK01 | Inventor | CHARRIER, Jean-Damien,
Vertex Pharmaceuticals Inc., Cottage Wing,
Station Rd,
Southam
Bishops Itchington,
Oxfordshire CV47 2QB, GB, MILLER, Andrew, Cherry Cottage Chilton Road Upton
Didcot, Oxfordshire OX11 9JL, GB, KNEGTEL, Ronald, 3 Bath Court,
Bath St
Abingdom,
Oxfordshire OX1X1EE, GB, GOLEC, Julian, 8 Manor Farm,
Chapel Road
Ashbury,
Wiltshire SN6 8LS, GB, BEBBINGTON, David, 6 Linden Close
Newbury, Berkshire R61 41QA, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 401/14 (2006.01) , C07D 403/12 (2006.01) | Title | Pyrazolforbindelser der er egnede som proteinkinaseinhibitorer | Int. application no. | US2001049401 | Int. publication no. | WO2002057259 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|